take 5
play

Take 5 How to Create Ownership in Your Team with Critical Drivers - PowerPoint PPT Presentation

Take 5 How to Create Ownership in Your Team with Critical Drivers Multiple Locations Conference Hugh Chancy, RPh Owner Chancy Drugs Learning Objective Discuss two peer-tested ideas that lead to business efficiencies and better patient care.


  1. Take 5 How to Create Ownership in Your Team with Critical Drivers Multiple Locations Conference Hugh Chancy, RPh Owner Chancy Drugs

  2. Learning Objective Discuss two peer-tested ideas that lead to business efficiencies and better patient care.

  3. Disclosure Hugh Chancy, RPh declares no conflicts of interest or financial interest in any product or service mentioned in this program, including grants, employment, gifts, stock holdings, and honoraria.

  4. What, Why, & How WHY WHAT HOW Method for addressing Improves financial health Identify focus areas • • • problem areas in your Increases team Define what success looks pharmacy • • engagement like Converts team members • from employees to owners Create less stressful Create a monthly • • environment scorecard Simultaneously create ROI • and an incentive program Frees up time to focus on Educate your team about • • for employees important initiatives the ‘WHY’ Drives consistent, long- • Gives employees a • term, positive results ‘purpose ’

  5. Critical Driver Benchmarks

  6. Gross profit per script • 5,000 scripts per month • Increase profit by $2 per script 5,000 scripts X $2 = $10,000 additional gross profit • Incentives paid to employees: $1500 • 7 employees: 1 Pharmacist- $500, 3 Techs- $250 each, 2 Clerks- $100 each, Delivery Driver- $50 $ 10,000 additional gross profit - $1500 incentives = $8500 net profit Win Win …. A win for the company and a win for the team!

  7. Questions? Hugh Chancy, RPh Chancy Drugs hughchancy@chancydrungs.com

  8. Take 5 High-End Supplements and Nutrient Depletion Multiple Locations Conference Tom Kelly, RPh Owner and Operator Medicine to Go

  9. Disclosure Tom Kelly, RPh declares no conflicts of interest or financial interest in any product or service mentioned in this program, including grants, employment, gifts, stock holdings, and honoraria.

  10. The pharmacist recommends taking GI Flora with this product. Take 2 capsules three times a day at least one hour apart from the Antibiotic. Keep GI Flora in the refrigerator.

  11. Questions? Tom Kelly, RPh Medicine to Go capsuleman@comcast.net

  12. NCPA’s Wildly Important Goals for Community Pharmacy Multiple Locations Conference March 2, 2019

  13. Learning objectives 1. Illustrate NCPA’s two wildly important goals for community pharmacy. 2. Discuss at least three current initiatives toward improved change in the community pharmacy marketplace. 3. Outline challenges of medical care organizations and how community- based pharmacies can help meet their needs. 4. Discuss the latest developments in enhanced service networks and best practices for care planning. 5. Describe advanced primary care medical home models that aim to strengthen primary care through multi – payer payment reform and care delivery transformation.

  14. Disclosure Doug Hoey, RPh declares no conflicts of interest or financial interest in any product or service mentioned in this program, including grants, employment, gifts, stock holdings, and honoraria.

  15. Changing the pharmacy payment model • Why is it necessary? • Number one issue for NCPA members almost always comes down to payment • Payment for products AND payment for services • The current pharmacy prescription drug payment model? • Complex • Costly • Confusing • Cumbersome • Most of all, COVERT • The whole system is a hot mess! • A payment model based on simplicity for consumers and taxpayers is needed.

  16. Changin ing th the pharmacy payment model • Mega-PBMs are the center of the Rx drug payment universe — change starts with their model • U.S. drug costs are the highest in the world…and the U.S. is the only country that has entrusted PBMs to control drug costs

  17. What does changing the pharmacy payment model mean to you? 1) Practice transformation; embracing being paid differently 2) Transparency, predictability for pharmacies and patients 3) Pharmacy owners are recognized for quality and value (educating plan sponsors) 4) Changing ingredient cost plus professional fee model of today e.g. a standardized payment formula like NADAC + used in Medicaid 5) Implement the WV Medicaid Managed Care model across the country 6) Helping plan sponsors make a different choice about the PBM they hire!

  18. Ch Changin ing th the pharm rmacy payment model 1) Changing the current PBM model to one that is truly transparent and functions as a claims processor rather than healthcare provider is just one step. 2) The entire supply chain must make adjustments — from plan sponsors to patients and everyone in-between.

  19. How will we know progress is being made to change the pharmacy payment model?

  20. NCPA’s unintentional past WIGs How do we as an organization have the most demonstrable impact on our members? Past WIGs: “NCPA will be a political powerhouse” • Million dollar PAC “We must have a Community pharmacy majority in Congress” • Congressional Pharmacy Caucus • Pharmacy visits “Adherence will be a pharmacist core competency by 2015.” • PAMA-Pharmacists Advancing Medication Adherence Simplify My Meds  • • Adherence work with pharmacy schools

  21. NCPA WIGs NCPA’s Wildly Important Goals (our WIGs) are focused in two areas: a) Changing the pharmacy benefit in Medicaid managed care programs b) Practice transformation

  22. Practice Transformation

  23. The Power of National and State Advocacy

  24. Department of Health & Human Services Centers for Medicare & Medicaid Services

  25. Community Pharmacy from Another Lens: Diary of a Washington Insider Multiple Locations Conference RADM (ret) Pamela Schweitzer, Pharm.D., BCACP Former Assistant Surgeon General 10 th Chief Pharmacist, United States Public Health Service

  26. Disclosure RADM (ret) Pamela Schweitzer, Pharm.D., BCACP declares no conflicts of interest or financial interest in any product or service mentioned in this program, including grants, employment, gifts, stock holdings, and honoraria.

  27. Elevator pitch – HHS/CMS • Understanding value • PBM versus health plan • Separate product from service • Collaboration with other providers

  28. Waiting for the right wave

  29. Product versus service Product Service Dispensing prescriptions, efficient workflow Time consuming clinical services Consult on Over-the-Counter medications Collaborative practice agreements Delivery of medications, mail-out Medication Therapy Management Dispensing of specialty drugs Relationships to other members of healthcare team Refill reminders Home monitoring, telemedicine/pharmacy Automation Personalized medicine Pharmacy contracts, network agreements Working with healthcare team to clean up medication profile – Rx Cancel, Blue Button Some clinical services - immunizations Patient advocate – patient knows pharmacists’ name

  30. Innovation • Automation for filling/dispensing of prescriptions • Solutions/automation to allow for aging in place. • Telepharmacy • Changing practice of pharmacy • Team-based care • Prevention/public health • Collaboration with community partners • Science – new drugs and delivery systems

  31. Smart medication monitoring and management – technology enabled care Smart Patch • Date/time applied • Duplicate patch? • Temperature • Expiration date • Wireless data transfer Data flowing back from “Smart” medications are presented in Smart Package exception management dashboards • Pill removed for review by Care Team members • Date/time log • Temperature • Expiration date 39 • Wireless data transfer

  32. 2019 advanced Alternative Payment Models (APM) • Bundled Payments for Care Improvement (BPCI) Advanced • Comprehensive ESRD Care (CEC) – Two-Sided Risk • Comprehensive Primary Care Plus (CPC+) • Next Generation Accountable Care Organization (ACO) • Maryland Total Cost of Care Model (Maryland Primary Care Program)

  33. CMS Innovation Center (CMMI) Example – Models (ongoing) that value optimize medication use: • Part D Enhanced Medication Therapy Management Model • Comprehensive Primary Care Plus • Independence at Home Demonstration • Partnership for Patients • Transforming Clinical Practice Initiative https://innovation.cms.gov/index.html

  34. New Part D payment models for 2020 In January 2020, CMMI will begin the Part D Payment Modernization model to test the impact of a revised Part D program design and incentive alignment on overall Part D prescription drug spending and beneficiary out-of-pocket costs. https://innovation.cms.gov/initiatives/part-d-payment- modernization-model/

  35. 2020 - Rewards and incentives

  36. Medicaid expanding scope of pharmacy practice Reference: CMCS Bulletin, January 17, 2017

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend